Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FDPS | P14324 | 1/20 | 0.49 |
| ▸ | ACHE | P22303 | 4/20 | 0.48 |
| ▸ | BCHE | P06276 | 3/20 | 0.48 |
| ▸ | PDE4A | P27815 | 1/20 | 0.47 |
| ▸ | PDE4B | Q07343 | 1/20 | 0.47 |
| ▸ | PDE4C | Q08493 | 1/20 | 0.47 |
| ▸ | PDE4D | Q08499 | 1/20 | 0.47 |
| ▸ | TNF | P01375 | 4/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.46 |
| ▸ | THRA | P10827 | 1/20 | 0.46 |
| ▸ | THRB | P10828 | 1/20 | 0.46 |
| ▸ | TSHR | P16473 | 1/20 | 0.45 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.44 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.44 |
| ▸ | PPARA | Q07869 | 1/20 | 0.44 |
| ▸ | LMNA | P02545 | 1/20 | 0.44 |
| ▸ | TP53 | P04637 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16334606 | 0.95 | FDPS (0.51) | FDPSACHEBCHEPDE4APDE4B | |
| SCHEMBL7370670 | 0.90 | PDE4A (0.56) | FDPSPDE4APDE4BPDE4CPDE4D | |
| SCHEMBL4344594 | 0.84 | HSD17B2 (0.56) | FDPSTHRATHRBTSHRLMNA | |
| SCHEMBL16146944 | 0.84 | PTGDR2 (0.54) | ALDH1A1TSHRCYP1A2CYP2C19LMNA | |
| SCHEMBL18554126 | 0.84 | FDPS (0.63) | FDPSACHEBCHEALDH1A1TSHR | |
| SCHEMBL16147875 | 0.82 | SMN1; SMN2 (0.45) | TNFCYP1A2LMNA | |
| SCHEMBL5106323 | 0.82 | ALDH1A1 (0.65) | FDPSALDH1A1TSHRCYP1A2CYP2C19 | |
| SCHEMBL3459019 | 0.82 | PTGDR2 (0.56) | ALDH1A1TSHRCYP1A2CYP2C19LMNA | |
| SCHEMBL4506605 | 0.80 | CYP4F2 (0.48) | TNFALDH1A1TSHRCYP1A2CYP2C19 | |
| SCHEMBL24384207 | 0.79 | MEN1 (0.46) | PDE4APDE4BPDE4CPDE4DALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090023926-A1 | Trityl Derivatives for Enhancing Mass Spectrometry | OXFORD GENE TECHNOLOGY IP LIMITED (GB) | 2009-01-22 | — | — | US | disclosed |
| US-20090023926-A1 | Trityl Derivatives for Enhancing Mass Spectrometry | OXFORD GENE TECHNOLOGY IP LIMITED (GB) | 2009-01-22 | — | — | US | disclosed |
| US-20090023926-A1 | Trityl Derivatives for Enhancing Mass Spectrometry | OXFORD GENE TECHNOLOGY IP LIMITED (GB) | 2009-01-22 | — | — | US | disclosed |
| EP-1802630-A2 | TRITYL DERIVATIVES FOR ENHANCING MASS SPECTROMETRY | OXFORD GENE TECHNOLOGY IP LIMITED (GB) | 2007-07-04 | — | — | EP | disclosed |
| WO-2006032893-A2 | TRITYL DERIVATIVES FOR ENHANCING MASS SPECTROMETRY | OXFORD GENE TECHNOLOGY IP LIMITED (GB) | 2006-03-30 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090023926-A1 | Trityl Derivatives for Enhancing Mass Spectrometry | F3, TBCA, GYPA | FDPS 1060/4885ACHE 2326/4885BCHE 3174/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.